Trim72 has been reported as a potential therapeutic target in a variety of human diseases, such as type 2 diabetes mellitus [36], ischemic heart disease [37], drug-induced liver injury [22] and severe burn injury [38]. The gene discussed is TRIM72; the disease is diabetes mellitus.